DUBLIN, July 13, 2021 /PRNewswire/ -- The "Gene Therapy - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global market for Gene Therapy estimated at US$970.5 Million in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at a CAGR of 19.5% over the period 2020-2027.
Viral, one of the segments analyzed in the report, is projected to grow at a 19.7% CAGR to reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Viral segment is readjusted to a revised 17.6% CAGR for the next 7-year period. This segment currently accounts for a 11.1% share of the global Gene Therapy market.
The U.S. Accounts for Over 53.7% of Global Market Size in 2020, While China is Forecast to Grow at a 25.1% CAGR for the Period of 2020-2027
The Gene Therapy market in the U.S. is estimated at US$521.3 Million in the year 2020. The country currently accounts for a 53.71% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$107.9 Million in the year 2027 trailing a CAGR of 25.1% through 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.3% and 18.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 18.6% CAGR while Rest of European market (as defined in the study) will reach US$107.9 Million by the year 2027.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- A Prelude to Gene Therapy
- Classification of Gene Therapies
- COVID-19 Causes Gene Therapy Market to Buckle & Collapse
- COVID-19 Impact on Different Aspects of Gene Therapy
- Manufacturing & Delivery
- Research & Clinical Development
- Commercial Operations & Access
- Managing Derailed Operations
- Focus on Clinical Development Programs
- Targeting Manufacturing & Delivery Strategies
- Securing Supplies
- Remote Working
- Gene Therapy Set to Witness Rapid Growth Post COVID-19
- By Vector Type
- Viral Vectors Account For A Major Share Of The Market
- Adeno-Associated Virus Vectors
- Lentivirus
- Non-Viral Vectors To Witness Faster Growth
- US and Europe Dominate the Gene Therapy Market
- Oncology Represents the Largest Indication for Gene Therapy
- Market Outlook
- WORLD BRANDS
2. FOCUS ON SELECT PLAYERS
- Recent Market Activity
- Select Innovations
- Abeona Therapeutics Inc.
- Adaptimmune Therapeutics Plc
- Advantagene, Inc.
- Adverum Biotechnologies, Inc
- Akcea Therapeutics
- Alnylam Pharmaceuticals, Inc.
- Amgen Inc
- Anchiano Therapeutics, Inc.
- AnGes, Inc.
- Applied Genetic Technologies Corporation
- Audentes Therapeutics, Inc.
- Biogen
- bluebird bio, Inc.
- Chiesi Farmaceutici S.p.A
- CRISPR Therapeutics AG
- Editas Medicine, Inc.
- Gilead Sciences, Inc.
- Intellia Therapeutics, Inc.
- Jazz Pharmaceuticals, plc.
- Juno Therapeutics, Inc
- Merck KGaA
- MolMed S.p.A.
- Novartis Gene Therapies
- Orchard Therapeutics plc
- REGENXBIO Inc.
- Sangamo Therapeutics, Inc.
- Sarepta Therapeutics, Inc.
- Sibiono GeneTech Co. Ltd.
- Spark Therapeutics, Inc.
- uniQure N.V.
- Voyager Therapeutics
3. MARKET TRENDS & DRIVERS
- Availability of Novel Therapies Drive Market Growth
- Select Approved Gene Therapy Products
- Adeno-associated Virus Vectors - A Leading Platform for Gene Therapy
- Lentiviral Vectors Witness Increasing Interest
- Rising Cancer Incidence Worldwide Spurs Demand for Gene Therapy
- Compelling Level of Technology & Innovation to Ignite Gene Therapy
- Promising Gene Therapy Innovations for Treatment of Inherited Retinal Diseases
- Gene Therapy Pivots M&A Activity in Dynamic Domain of Genomic Medicine
- M&As Rampant in Gene Therapy Space
- Gene Therapy Deals: 2018 and 2019
- Emphasis on Formulating Robust Regulatory Framework
- Strong Gene Therapy Pipeline
- Gene Therapy: Phase III Clinical Trials
- OHSU Implements First-Ever LCA10 Gene Therapy Clinical Trial with CRISPR
- Growing Funding for Gene Therapy Research
- Market Issues & Challenges
4. GLOBAL MARKET PERSPECTIVE
III. REGIONAL MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 154
For more information about this report visit https://www.researchandmarkets.com/r/4dxddh
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
